264 related articles for article (PubMed ID: 2005075)
1. Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.
Deltito JA; Argyle N; Klerman GL
J Clin Psychiatry; 1991 Mar; 52(3):121-7. PubMed ID: 2005075
[TBL] [Abstract][Full Text] [Related]
2. Alprazolam in the treatment of panic attack patients with and without major depression.
Pyke RE; Kraus M
J Clin Psychiatry; 1988 Feb; 49(2):66-8. PubMed ID: 3338978
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the effect of alprazolam, imipramine and placebo in the treatment of panic disorders in Cali, Colombia].
León CA; De Arango MV; Arevalo W; Calvo A; Montoya A; León A
Acta Psiquiatr Psicol Am Lat; 1990; 36(1-2):59-72. PubMed ID: 2073024
[TBL] [Abstract][Full Text] [Related]
4. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
Charney DS; Woods SW; Goodman WK; Rifkin B; Kinch M; Aiken B; Quadrino LM; Heninger GR
J Clin Psychiatry; 1986 Dec; 47(12):580-6. PubMed ID: 3536889
[TBL] [Abstract][Full Text] [Related]
5. Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial.
Tesar GE; Rosenbaum JF; Pollack MH; Herman JB; Sachs GS; Mahoney EM; Cohen LS; McNamara M; Goldstein S
J Clin Psychiatry; 1987 Oct; 48 Suppl():16-21. PubMed ID: 3312179
[TBL] [Abstract][Full Text] [Related]
6. Comparative studies of pharmacotherapy for school refusal.
Bernstein GA; Garfinkel BD; Borchardt CM
J Am Acad Child Adolesc Psychiatry; 1990 Sep; 29(5):773-81. PubMed ID: 2228932
[TBL] [Abstract][Full Text] [Related]
7. Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment.
Rosenberg R; Bech P; Mellergård M; Ottosson JO
Acta Psychiatr Scand Suppl; 1991; 365():39-45. PubMed ID: 1862733
[TBL] [Abstract][Full Text] [Related]
8. A double-blind clinical trial of alprazolam, imipramine, or placebo in the depressed elderly.
Weissman MM; Prusoff B; Sholomskas AJ; Greenwald S
J Clin Psychopharmacol; 1992 Jun; 12(3):175-82. PubMed ID: 1629383
[TBL] [Abstract][Full Text] [Related]
9. The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
Zajecka JM
J Clin Psychiatry; 1996; 57 Suppl 2():10-4. PubMed ID: 8626357
[TBL] [Abstract][Full Text] [Related]
10. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.
Tesar GE; Rosenbaum JF; Pollack MH; Otto MW; Sachs GS; Herman JB; Cohen LS; Spier SA
J Clin Psychiatry; 1991 Feb; 52(2):69-76. PubMed ID: 1993639
[TBL] [Abstract][Full Text] [Related]
11. [Patients with panic disorder: a 5-year follow-up study].
León CA; Arévalo W; Gaviria LF; Leon A
Acta Psiquiatr Psicol Am Lat; 1992 Dec; 38(4):279-88. PubMed ID: 1341123
[TBL] [Abstract][Full Text] [Related]
12. A comparison of symptom determinants of patient and clinician global ratings in patients with panic disorder and depression.
Leon AC; Shear MK; Klerman GL; Portera L; Rosenbaum JF; Goldenberg I
J Clin Psychopharmacol; 1993 Oct; 13(5):327-31. PubMed ID: 8227491
[TBL] [Abstract][Full Text] [Related]
13. Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo.
Pollack MH; Otto MW; Sachs GS; Leon A; Shear MK; Deltito JA; Keller MB; Rosenbaum JF
J Affect Disord; 1994 Apr; 30(4):273-81. PubMed ID: 8014326
[TBL] [Abstract][Full Text] [Related]
14. Paroxetine in major depression: a double-blind trial with imipramine and placebo.
Cohn JB; Wilcox CS
J Clin Psychiatry; 1992 Feb; 53 Suppl():52-6. PubMed ID: 1531826
[TBL] [Abstract][Full Text] [Related]
15. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
Fawcett J; Marcus RN; Anton SF; O'Brien K; Schwiderski U
J Clin Psychiatry; 1995; 56 Suppl 6():37-42. PubMed ID: 7649972
[TBL] [Abstract][Full Text] [Related]
16. Psychopharmacologic validation of atypical depression.
Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin JG; Tricamo E; Markowitz JS; Klein DF
J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):22-5. PubMed ID: 6376483
[TBL] [Abstract][Full Text] [Related]
17. An open-label trial of nefazodone in high comorbidity panic disorder.
DeMartinis NA; Schweizer E; Rickels K
J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561
[TBL] [Abstract][Full Text] [Related]
18. Surreptitious drug use by patients in a panic disorder study.
Clark DB; Taylor CB; Roth WT; Hayward C; Ehlers A; Margraf J; Agras WS
Am J Psychiatry; 1990 Apr; 147(4):507-9. PubMed ID: 1969248
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature.
Jonas JM; Cohon MS
J Clin Psychiatry; 1993 Oct; 54 Suppl():25-45; discussion 46-8. PubMed ID: 8262888
[TBL] [Abstract][Full Text] [Related]
20. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo.
Keller MB; Lavori PW; Goldenberg IM; Baker LA; Pollack MH; Sachs GS; Rosenbaum JF; Deltito JA; Leon A; Shear K
J Affect Disord; 1993 May; 28(1):27-38. PubMed ID: 8326078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
